Blog

Treated Like a Human, Not a Statistic

Virtual clinical trial access program provided breast cancer patients with personal, in-home treatment during the…

Blog

A Conversation with Freenome and Jonathan Cotliar, M.D., Chief Medical Officer, Science 37

In a few words, what is Science 37 and what is the benefit of decentralized…

Report

How to Save an At-Risk Clinical Trial

How can you rescue an at-risk clinical trial without compromising quality? Delays in clinical research…

Blog

Top Five Reasons to Include Virtual Sites in Your Infectious Disease Research

Author: Debra Weinstein, MD, Vice President - Internal Medicine Virtual sites can help deliver infectious…

Blog

4 Things to Know about the EMA’s Updated Decentralized Clinical Trial Recommendations

Authors: Jen Davis, Deputy General Counsel & Chief Privacy Officer and Silvia Chia, Senior Director…

Blog

Science 37 Forecast—The Adoption of Hybrid Oncology Trials Will Accelerate in 2023 & Beyond

Author: Dr. Shaalan Beg, Vice President, Oncology Oncology is a therapeutic area of singular importance…

Blog

What Clinical Trial Patient Participants Want

Author: Darcy Forman, Chief Delivery Officer, Science 37 In clinical trials, participant satisfaction is critical…

Report

Clinical Decision Makers Confirm a Shift to Hybrid and Decentralized Studies

Clinical research is undergoing transformation across the board—but how will it impact oncology clinical trials?…

Webinar

Decentralization in Action: What Oncology Trials Look Like Now

What current clinical research looks like with oncology trials

Webinar

What Clinical Trial Participants Want — And How Sponsors can Deliver

Science 37 carefully examines all clinical trial options and elements needed for research — helping…

Report

Decentralized Clinical Trials — Is There a Positive Return on Investment on a Virtual Site?

Across the Life Sciences industry, there has been much talk about the cost and value…

Webinar

Webinar—How Decentralized Clinical Trials are Impacting Research

Learn more about agile technologies and industry standards that are needed to drive clinical trial…